Curium Announces Strategic Partnership with PeptiDream for Prostate Cancer Theranostics in Japan


PARIS, Curium, a world leader in nuclear medicine, announced today that it has entered into a strategic partnership with PDRadiopharma Inc, a wholly-owned subsidiary of PeptiDream, for the clinical development, regulatory filing, and commercialization in Japan of 177Lu-PSMA-IandT and 64Cu-PSMA-IandT. The two agents 177Lu-PSMA-IandT and 64Cu-PSMA-IandT target prostate specific membrane antigen (PSMA) expressed on prostate cancer cells and are being investigated for prostate cancer treatment and diagnostics. Both target tumors with high levels of PSMA expression and thus potentially forming a theranostic (therapeutic and diagnostic) pair.

Under the terms of the partnership, Curium and PDRadiopharma will jointly collaborate on clinical development activities of 177Lu-PSMA-IandT and 64Cu-PSMA-IandT in Japan, with PDRadiopharma leading regulatory filing, manufacturing, commercialization, and distribution activities in Japan. Curium will continue to lead global development of the two agents and support PDRadiopha
rma through technology transfer to support the set-up of manufacturing lines in Japan – including a high throughput Copper 64 manufacturing line based on Curium’s proprietary technology.

Source: BERNAMA News Agency

  • malaysiang

    Related Posts

    MIDA Connects Investors With Local Talent Through Innovative Pathways – CEO

    KUALA LUMPUR, The Malaysian Investment Development Authority (MIDA) is actively crafting innovative and strategic pathways, connecting investors and industry players with local talent to meet the ever-evolving demands of the industry.

    In an exclusive…

    Thai experts support sustainable community-based tourism development in Ben Tre

    The Thailand International Cooperation Agency (TICA), under the country’s Ministry of Foreign Affairs of Thailand, on October 15 officially handed over a project on sustainable coastal community development through ecotourism and the application of th…